Bivalent COVID-19 jabs need prescription – FDA inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.
The Food and Drug Administration (FDA) Center for Drug Regulation and Research (CDRR) has finally released 408 Automatic Renewal (AR) drug applications weeks after receiving a show-cause order from the Anti-Red Tape Authority (ARTA).
ARTA ARTA made the statement after it ordered FDA-CDRR directo
Anti-Red Tape Authority (ARTA) Director-General Jeremiah Belgica (Photo from ARTA)
ARTA Director-General Jeremiah Belgica made the statement after ARTA issued a show-cause order FDA Center for Drug Regulation and Research (CDRR) Director IV Jesusa Cirunay to “explain why no administrative or criminal case should be filed” against her for supposedly sitting on over 600 drug applications filed since 2014 despite completeness of submission of various pharmaceutical companies.
In a virtual public briefing, Belgica asked Health Secretary Francisco Duque III and FDA Director-General Eric Domingo to cleanse the FDA as he pointed out that more complaints against the agency are pouring in.
“Iyong reklamo hong pumapasok, Center for Drugs pero pati rin ho sa ibang mga centers ay may mga pumapasok na din po sa amin na mga affidavits (The complaints we have are for the CDRR but we have affidavits coming in complaining about other centers of the FDA),” he said during the Laging Handa br
Published May 13, 2021, 12:31 PM
The Anti-Red Tape Authority (ARTA) said it is now preparing to endorse government employees and officials under its investigation to the Presidential Anti-Corruption Commission (PACC) for lifestyle checks.
In a radio interview, ARTA Director General Jeremiah Belgica revealed the agency’s move following the continuing delays in the processing of permit applications for various products at the Food and Drug Administration (FDA).
Executive Order (EO) No. 43 s.2017, as amended by EO No. 73 s.2017, states that the PACC “may, upon instructions of the President, or motu propio, conduct lifestyle checks and fact-finding inquiries on acts or omissions of all presidential appointees, including those outside the Executive Branch of government.”
Food and Drug Administration (FDA)
“Ang FDA will cooperate fully with the authorities sa pag-investigate nito para makita po natin kung meron nga pong problema (The FDA will cooperate fully with the authorities in investigating this, so we can determine if there are problems),” said FDA Director-General Rolando Enrique Domingo in a radio interview on Wednesday, May 12.
Domingo said that his agency’s legal service office is currently looking at the matter.
“Yung aming legal service ngayon ay tumutulong na rin na hanapin itong mga applications na ito para malaman kung may pagkukulang man o may problema talaga at hindi naaaksyunan (Our legal service is now also helping in finding these applications to know if there are any shortcomings or problems, or inactions),” he said.